Botulinum toxin as a novel therapeutic approach for auriculotemporal neuralgia

• Tipo: Artigo em Revista Científica Internacional
• Data: 2021

Autores

Pinto, MJ (Autor) FMUP; Guerrero, AL (Autor) Outra; Costa, A (Autor) Outra

Revista

Título: Headache

Vol. 61

Páginas: 392-395

ISSN: 0017-8748

Editora: Wiley-Blackwell

Indexação

ISI Web of Knowledge - 2 Citações

Scopus - 2 Citações

Outras Informações

ID Authenticus: P-00T-ABR

DOI: 10.1111/head.14043

Abstract (EN): Objectives/Background: Auriculotemporal neuralgia is a rare headache disorder. Anesthetic nerve blockade seems to be effective in most cases; however, literature is scarce about the management of refractory cases. Methods: Case report. Results: We report a 44-year-old woman with migraine without aura presented with moderate-to-severe right temporoparietal headache. The pain was refractory to multiple pharmacological strategies, including intravenous analgesia. A more throughout examination lead to the diagnosis of auriculotemporal neuralgia and anesthetic nerve blocks were performed. Due to early pain recrudescence, botulinum toxin (BoNT) was tried with better and longstanding pain control. Conclusion: BoNT may be a useful treatment option in refractory auriculotemporal neuralgia. The best approach is yet to be established; however, the "follow-the-pain" protocol may be a reasonable option.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 4